1.68
price down icon6.15%   -0.11
after-market アフターアワーズ: 1.66 -0.02 -1.19%
loading

Soligenix Inc (SNGX) 最新ニュース

pulisher
Oct 12, 2025

Soligenix Inc.’s volatility index tracking explained2025 Price Momentum & Low Drawdown Momentum Trade Ideas - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Why analysts raise outlook for Soligenix Inc. (DOA0) stock2025 Trading Recap & Daily Growth Stock Investment Tips - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

Soligenix (NASDAQ: SNGX) Expands European Medical Advisory Board, Advances Phase 3 Study to Support HyBryte(TM) Development for CTCL - The Globe and Mail

Oct 10, 2025
pulisher
Oct 10, 2025

Is Soligenix Inc. (DOA) stock overpriced at current multiplesWeekly Stock Report & Real-Time Sentiment Analysis - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

What machine learning models say about Soligenix Inc.Weekly Investment Report & Entry Point Confirmation Signals - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Soligenix Inc. stock retracement – recovery analysisJuly 2025 Summary & Real-Time Stock Price Movement Reports - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Applying chart zones and confluence areas to Soligenix Inc.Portfolio Performance Report & Low Drawdown Momentum Trade Ideas - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Soligenix Expands European Advisory Board to Advance CTCL Treatment Development - citybuzz

Oct 09, 2025
pulisher
Oct 09, 2025

Does Soligenix Inc. show high probability of reboundShare Buyback & Growth Focused Stock Pick Reports - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Will Soligenix Inc. stock recover after recent dropJuly 2025 Trade Ideas & Safe Capital Growth Plans - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

How to manage a losing position in Soligenix Inc.July 2025 Momentum & Short-Term High Return Strategies - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Soligenix (NASDAQ: SNGX) Reports Positive Safety Review from DMC in Ongoing Phase 3 FLASH2 Study of HyBryte for CTCL - Digital Journal

Oct 08, 2025
pulisher
Oct 08, 2025

Biotech and Medical Tech Stocks Report Breakthrough Clinical Trial Updates - MarketScreener

Oct 08, 2025
pulisher
Oct 08, 2025

EV PD-L1 Decreases in 3 Patients: Aethlon Medical Hemopurifier Shows Early EV, miRNA and T‑cell Changes - Stock Titan

Oct 08, 2025
pulisher
Oct 07, 2025

Soligenix Reports Positive Safety Review in Phase 3 CTCL Treatment Trial - citybuzz

Oct 07, 2025
pulisher
Oct 07, 2025

Soligenix Stock (SNGX) Opinions on Phase 3 HyBryte™ Safety Milestone - Quiver Quantitative

Oct 07, 2025
pulisher
Oct 07, 2025

Soligenix’s Strategic Moves: A Bright Future Ahead? - timothysykes.com

Oct 07, 2025
pulisher
Oct 07, 2025

Soligenix shares surge after safety milestone in Phase 3 CTCL trial - MSN

Oct 07, 2025
pulisher
Oct 07, 2025

Soligenix stock soars after DMC confirms safety in Phase 3 CTCL study - Investing.com

Oct 07, 2025
pulisher
Oct 07, 2025

Soligenix (SNGX) Advances Phase 3 CTCL Study with Positive Safet - GuruFocus

Oct 07, 2025
pulisher
Oct 07, 2025

Soligenix’s HyBryte achieves safety milestone in Phase 3 T-cell lymphoma trial - TipRanks

Oct 07, 2025
pulisher
Oct 07, 2025

Soligenix achieves important safety milestone in its confirmatory phase 3 Clinical Trial of HyBryte(TM) for the treatment of cutaneous T-cell lymphoma - MarketScreener

Oct 07, 2025
pulisher
Oct 07, 2025

Soligenix reports safety milestone in phase 3 CTCL treatment trial By Investing.com - Investing.com Canada

Oct 07, 2025
pulisher
Oct 07, 2025

Soligenix reports safety milestone in phase 3 CTCL treatment trial - Investing.com

Oct 07, 2025
pulisher
Oct 07, 2025

Soligenix Achieves Important Safety Milestone in its Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma - PR Newswire

Oct 07, 2025
pulisher
Oct 07, 2025

What analysts say about Soligenix Inc DOA stockEarnings Per Share Trends & Learn to Pick Stocks in Under 10 Minutes - earlytimes.in

Oct 07, 2025
pulisher
Oct 06, 2025

Has Soligenix Inc. formed a bullish divergence2025 Retail Activity & Verified Entry Point Signals - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Regression analysis insights on Soligenix Inc. performance2025 Trade Ideas & Weekly Momentum Picks - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Should you hold or exit Soligenix Inc. nowBear Alert & Verified Swing Trading Watchlists - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Using AI based signals to follow Soligenix Inc.Weekly Stock Summary & Consistent Income Trade Recommendations - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Why Soligenix Inc. (DOA0) stock is trending on social media2025 Top Decliners & Daily Profit Focused Stock Screening - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Statistical indicators supporting Soligenix Inc.’s strengthWeekly Stock Report & Low Volatility Stock Recommendations - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Using economic indicators to assess Soligenix Inc. potentialTrade Exit Report & Consistent Profit Trading Strategies - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Is Soligenix Inc. (DOA) stock a momentum leaderQuarterly Market Review & Daily Price Action Insights - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Is Soligenix Inc. stock ready for a breakoutEarnings Growth Summary & Consistent Return Strategy Ideas - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Insider Buying: Christopher Schaber Acquires Shares of Soligenix Inc (SNGX) - GuruFocus

Oct 03, 2025
pulisher
Oct 03, 2025

Can trapped investors hope for a rebound in Soligenix Inc.Day Trade & Daily Profit Focused Screening - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Why Soligenix Inc. (DOA0) stock remains top ratedJuly 2025 Patterns & Smart Swing Trading Techniques - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

What downside risks could hit Soligenix Inc. (DOA0) stock2025 Risk Factors & Weekly Setup with ROI Potential - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Will Soligenix Inc. stock deliver long term returnsSell Signal & Community Consensus Trade Alerts - newser.com

Oct 02, 2025
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
大文字化:     |  ボリューム (24 時間):